Oxford Biomedical Technologies

https://cdn.nutrition.org/article/S2475-2991(24)00325-1/fulltext
Latest published research presented at the American Society for Nutrition 2024 Conference in Chicago!

Effectiveness of a Patient-Specific Oligoantigenic Diet on Global Symptoms for Irritable Bowel Syndrome Objectives: To investigate the effectiveness of a 12-week patient-specific oligoantigenic diet on global symptomatology for irritable bowel syndrome (IBS).

Congratulations! Your abstract "A Novel Tailored Oligoantigenic Dietary Approach for Irritable Bowel Syndrome (IBS)" was peer reviewed for the 2024 Food & Nutrition Conference & Expo™ (FNCE®) and selected for a poster session.

Congratulations! On behalf of the American Society for Nutrition, we are delighted to notify you that your abstract has been accepted for presentation at NUTRITION 2024.
Abstract Title: Effectiveness of a Patient-Specific Oligoantigenic Diet on Global Symptoms for Irritable Bowel Syndrome.

Latest Publication Presented at FNCE 2023 from the Research Department at Oxford Biomedical Technologies, Inc.

Clinical Response to Personalized Dietary Therapy for Irritable Bowel Syndrome (IBS) Provide scientific evidence to support the improvement of nutrition and overall health care for individuals with medical conditions.

Hello Everybody,
FNCE is quickly approaching! Below is the information for the poster session that Oxford Biomedical Technologies is presenting.

Clinical Response to Personalized Dietary Therapy for Irritable Bowel Syndrome (IBS)
Sunday October 8, 2023
11:45 AM – 1:15 PM
Your Role: Poster Presenter
Poster Number: 57

FREE Full Text Access - Oxford Biomedical Technologies Publication.
Please review the findings from our research on the clinical effectiveness of the Lifestyle Eating and Performance (LEAP) program based on the Leukocyte Activation Assay-MRT (LAA-MRT) results in improving IBS symptoms and quality of life.

Is Personalized Dietary Therapy Effective for Individuals With Irritable Bowel Syndrome? - PubMed Introduction: Adverse reactions to foods and food additives have a critical role in clinical manifestations of irritable bowel syndrome (IBS). Personalized dietary modifications conducted under the supervision of a qualified health practitioner could considerably impact the clinical car...

Your abstract was peer reviewed for the 2023 Food & Nutrition Conference & Expo™ (FNCE®) and selected for a poster session. FNCE® will be held October 7-10, 2023 in Denver, CO at the Colorado Convention Center.

Congratulations! On behalf of the American Society for Nutrition, we are delighted to notify you that your abstract has been accepted for presentation at NUTRITION 2023.
Abstract Title: Evaluation of the Lifestyle Eating and Performance (LEAP) Program To Manage Symptoms and Quality of Life for Irritable Bowel Syndrome (IBS).

We were very pleased with the scope and quality of the submissions, and are happy to inform you that the abstract entitled “Effectiveness of the Lifestyle Eating and Performance (LEAP) program for Irritable Bowel Syndrome (IBS)” was accepted for the Lifestyle Medicine 2022 conference!

Dr. Zarini & Dr. McLean, Congratulations on having your abstract accepted for poster presentation at the ACG 2022 Annual Scientific Meeting!

Congratulations! Your abstract was peer reviewed for the 2022 Food & Nutrition Conference & Expo™ (FNCE®) and selected for a poster session. FNCE® will be held October 8-11, 2022 in Orlando, FL at the Orange County Convention Center.
This agreement is for your poster presentation titled:
Personalized dietary intervention for women with depression and anxiety
Sunday October 9, 2022
11:45 AM – 1:15 PM

Functional Diagnostic Nutrition: [FREE TRAINING] The Mediator Release Test (MRT): An Advanced and Innovative Diagnostic Tool Used to Unmask the Foods that Contribute to your Diet-Induced Inflammation.
👉 We talk a lot about the importance of functional lab testing and NOW is your opportunity to learn from an expert about one of our top tests!
📆 Join us SATURDAY, April 2, 2022, from 8:30 am - 10:30 am PST as we bring Dr. Michael Andrew McLean from Oxford Biomedical Technologies.
Join us and Learn:
✅ Overview of the MRT food sensitivity test
✅ Discuss the mechanism of inflammatory proteins response mediators released due to adverse food antigen exposure
✅ Test results “clinical significance” and expectations
✅ Case study – IBS and Migraine
If you cannot attend, be sure to register so a replay can be sent to you!
Register Now 👉 https://www.functionaldiagnosticnutrition.com/register

Abstract Notification for NUTRITION 2022 LIVE ONLINE: Abstract Accepted.
Abstract Title: Study Protocol: Effectiveness of the Lifestyle Eating and Performance (LEAP) Program for the Treatment of Irritable Bowel Syndrome (IBS).
Congratulations! On behalf of the American Society for Nutrition, we are delighted to confirm that your abstract has been accepted for presentation at NUTRITION 2022 LIVE ONLINE.

You can join a new in-person research study for IBS in Palm Beach, Florida. Oxford Biomedical Technologies, Inc. is assessing the effectiveness of the Lifestyle Eating and Performance (LEAP) program for the treatment of IBS. Please email [email protected] or call us at (561) 848-7111 Ext. 714. Fill out the participation request form https://www.nowleap.com/research/IBSStudy
The study requires 6 in-person visits and 1 virtual visit over a 3-month period, and participants will be compensated.

IBS Research Study - Oxford Biomedical Technologies, Inc. Oxford Biomedical Technologies is recruiting participants for a new clinical research study to determine the effectiveness of the Lifestyle Eating and Performance (LEAP) Program for people with irritable bowel syndrome (IBS).

Clinical and Anthropometric Improvements with a Tailored Dietary Approach in Pediatric Crohn's Disease - PubMed Pediatric Crohn's disease (CD) is more common today than in prior decades. Therapeutic goals in children with CD are to reduce symptomatology, promote normal growth, and avoid nutritional deficiencies. Diet plays a crucial role in the treatment of CD. However, there is a lack of comprehensive guidel...